A very disappointing and poorly considered decision. A waiver of IP will not accelerate availability of vaccines for developing countries.

Opportunities like the Alnylam Pharmaceuticals MassBio apprenticeship empower non-traditional candidates to fill vital roles in our workforce. These programs are paving the way to a bright and equitable future. bostonherald.com/2021/07/27/mas…

Great recognition from MA Legislative Manufacturing Caucus for Alnylam Pharmaceuticals's contribution to #AdvancedManufacturing. Proud to have our Alnylam Global Manufacturing Operations group making #RNAitherapeutics here in MA, close to our R&D operations!

Alnylam Pharmaceuticals (Alnylam Pharmaceuticals) has been named No. 1 Largest Company in Globe Magazine’s #TopPlacesToWork2021 issue. Why? Its mission. Read the full list here. bos.gl/IKSXwct

Have you heard the news? We're deeply honored and so #AlnylamProud! We're also hiring. You can search 100+ open positions in wide variety of roles here: bit.ly/31kXQ7S Is this #yourALNYmoment to say "CHALLENGE ACCEPTED" and join us? #TopPlacesToWork2021 #alnylamcareers

This thing has rapidly become the world’s exasperating good news/bad news story. If your head isn’t spinning, you’re not paying attention. A 🧵on my take on both the good news & the bad, with an emphasis on the things that have changed in the past few days... or minutes.(1/25)

I’ve been tweeting about Covid for nearly 2 years. But this week it became personal when my 28-year-old younger son got it. With his permission, I’ll describe his experience & how I approached his situation, given the realities of life and the rapidly changing evidence.(1/25)

An incredibly insightful, human story that matches clinical and medical insights with parenting. Thank you Bob Wachter for your on-going lessons about covid and your experiences at UCSF!

What’s so Gr8 about this story is that it was a skunkworks project… completely “unsanctioned” work by Alnylam Pharmaceuticals scientists exploring the improbable! Vasant Jadhav #kainotomia

We’re thrilled to share the news that we have received U.S. FDA approval for AMVUTTRA (vutrisiran), the fifth #RNAi therapeutic developed by Alnyam to receive regulatory approval in less than four years. #raredisease #biotech #RNAitherapeutics #siRNA

We are pleased to share topline results from our APOLLO-B phase 3 study of patisiran, an investigational #RNAi therapeutic in development for the treatment of #ATTR #amyloidosis with cardiomyopathy. #RNAitherapeutics #siRNA

We’ve shared topline results from our APOLLO-B phase 3 study of patisiran, an investigational #RNAi therapeutic in development for the treatment of #ATTR #amyloidosis w/ cardiomyopathy. We’ll present full results at #ISA_2022 in September. #RNAitherapeutics #siRNA

Fast Company's 100 Best Workplaces for Innovators list has Alnylam Pharmaceuticals at #1, NYC's Maven Clinic at #2, Roblox at #3, Microsoft at #24, Genentech at #36, Johns Hopkins Applied Physics Lab at #39, Doximity at #53, athenahealth at 58, Google at 85, BMS at 96 fastcompany.com/best-workplace…

Do we really want fewer medicines for rare diseases and cancer? The Inflation Reduction Act is already having life-changing consequences! We need a tailored fix here to avoid collateral damage for patients! wsj.com/articles/the-i…

Recently, I had the pleasure of visiting Alnylam Pharmaceuticals, a #lifesciences company that focuses on rare disease therapies in Cambridge. Alnylam has led the translation of RNAi (RNA interference) from a Nobel Prize-winning discovery into an innovative, entirely new class of medicines.

After six incredible years, late last month I elected to step back from my role at Alnylam. It has been a privilege and great honor to have played a small part in building Alnylam’s amazing success and, most importantly, helping many patients. It is hard…lnkd.in/ezcZN6Jt

This morning on Squawk Box, I talked about the surge of anti-Jewish hate on social media this wknd. People are glorifying terrorists & legitimizing murderers. As they've been doing for years, they’re objectifying Jews & dehumanizing Zionists as if they were animals. Let's be

Today, I’m giving a major address on the Senate floor on the dangerous and disturbing rise of antisemitism in America. Watch live: x.com/i/broadcasts/1…

Fantastic news. John is a phenomenal leader and visionary.

this reversal on uniqure is frankly worse than replimmune (and sarepta). like replimmune fda staff aligned with uniqure on a plan for approval, and qure hit the agreed upon bar. like sarepta, huntington patients and their doctors are crying out for this option, and have been